Is DaVita (DVA) overvalued or fairly valued?

MarketChacha shows DaVita's valuation in context — a forward P/E of about 13.5 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of DaVita (DVA)?

DaVita last traded at $232.83 (-1.9% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

DaVita

DVA · NYSE · Healthcare · United States

$232.83-1.9%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 5:38 PM

Snapshot

TickerDVA

ExchangeNYSE

SectorHealthcare

IndustryMedical Care Facilities

CountryUnited States

Employees78,000

HeadquartersDenver, United States

Market cap$14.9B

Volume189.02K

Websitewww.davita.com

Filings tracked0

About DaVita

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Profile as reported by Yahoo Finance.

Who owns it

Insiders46.9%
Institutions53.0%
Public & other0.1%

822 institutional holders

As reported by Yahoo Finance.

Top holders

Berkshire Hathaway, Inc46.89%
Blackrock Inc.4.31%
Vanguard Capital Management LLC3.40%
Morgan Stanley2.60%
Vanguard Portfolio Management LLC2.30%
Invesco Ltd.2.29%
State Street Corporation2.11%
Dimensional Fund Advisors LP1.78%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $3.5B · EPS 3.92

Est. earnings growth +56.3%

Next fiscal year

Rev $14.6B · EPS 17.22

Est. earnings growth +16.2%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$101.0052-wk range$239.64

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about DVA

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.